Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Exact Sciences Corp (EXAS) since 2001 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Exact Sciences Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1124140.
Total stock buying since 2001: $1,792,411.
Total stock sales since 2001: $327,519,821.
Total stock option exercises since 2001: $31,007,777.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 4,692 | $233,011 | 192,859 | $1,493,260 |
| 2024 | 19,500 | $1,001,325 | 106,368 | $6,444,968 | 252,334 | $1,435,604 |
| 2023 | 0 | $0 | 152,617 | $10,776,985 | 180,827 | $90,480 |
| 2022 | 0 | $0 | 123,980 | $8,214,810 | 696,995 | $14,410,352 |
| 2021 | 0 | $0 | 472,513 | $59,803,671 | 302,420 | $2,613,303 |
| 2020 | 0 | $0 | 370,067 | $36,422,904 | 204,388 | $3,203,683 |
| 2019 | 0 | $0 | 899,722 | $77,172,301 | 1,065,274 | $499,480 |
| 2018 | 0 | $0 | 912,540 | $51,810,433 | 810,073 | $1,235,546 |
| 2017 | 2,500 | $94,275 | 927,800 | $46,534,212 | 950,185 | $2,726,466 |
| 2016 | 92,155 | $696,811 | 1,527,810 | $26,291,768 | 2,436,900 | $3,190,873 |
| 2015 | 0 | $0 | 81,727 | $1,976,888 | 329,423 | $108,730 |
| 2014 | 0 | $0 | 0 | $0 | 33,601 | $0 |
| 2001 | 0 | $0 | 17,000 | $1,837,870 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-11-01 | Lidgard Graham Peter (Chief Science Officer) | Sale | 45,775 | 53.62 | 2,454,592 |
| 2017-10-02 | Coward D Scott (SVP and General Counsel) | Sale | 29,115 | 47.16 | 1,372,917 |
| 2017-10-02 | Lidgard Graham Peter (Chief Science Officer) | Sale | 81,025 | 47.16 | 3,820,733 |
| 2017-10-02 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 35,250 | 13.96 | 492,090 |
| 2017-09-29 | Coward D Scott (SVP and General Counsel) | Option Ex | 4,688 | .00 | 0 |
| 2017-09-06 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 42,317 | 9.95 | 420,842 |
| 2017-09-05 | Lidgard Graham Peter (Chief Science Officer) | Sale | 75,683 | 41.08 | 3,108,679 |
| 2017-09-05 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 75,683 | 12.24 | 926,586 |
| 2017-09-01 | Lidgard Graham Peter (Chief Science Officer) | Sale | 45,775 | 41.49 | 1,899,204 |
| 2017-08-28 | Thompson David (Director) | Option Ex | 52,472 | 6.82 | 357,649 |
| 2017-08-17 | Carey Thomas D. (Director) | Buy | 2,500 | 37.71 | 94,275 |
| 2017-08-17 | Conroy Kevin T (President and CEO) | Option Ex | 9,242 | 10.82 | 99,998 |
| 2017-07-31 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 5,846 | 39.41 | 230,390 |
| 2017-07-28 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 18,750 | .00 | 0 |
| 2017-07-03 | Coward D Scott (SVP and General Counsel) | Sale | 1,987 | 35.21 | 69,962 |
| 2017-06-30 | Coward D Scott (SVP and General Counsel) | Option Ex | 4,687 | .00 | 0 |
| 2017-04-03 | Coward D Scott (SVP and General Counsel) | Sale | 1,543 | 23.74 | 36,630 |
| 2017-03-31 | Coward D Scott (SVP and General Counsel) | Option Ex | 4,688 | .00 | 0 |
| 2017-03-13 | Conroy Kevin T (President and CEO) | Sale | 12,059 | 21.16 | 255,168 |
| 2017-03-13 | Arora Maneesh (COO) | Sale | 5,574 | 21.16 | 117,945 |
| 2017-03-13 | Coward D Scott (SVP and General Counsel) | Sale | 1,983 | 21.16 | 41,960 |
| 2017-03-13 | Lidgard Graham Peter (Chief Science Officer) | Sale | 2,945 | 21.16 | 62,316 |
| 2017-03-09 | Conroy Kevin T (President and CEO) | Option Ex | 24,400 | .00 | 0 |
| 2017-03-09 | Arora Maneesh (COO) | Option Ex | 11,275 | .00 | 0 |
| 2017-03-09 | Coward D Scott (SVP and General Counsel) | Option Ex | 6,025 | .00 | 0 |
| 2017-03-09 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 8,425 | .00 | 0 |
| 2017-02-27 | Conroy Kevin T (President and CEO) | Sale | 19,557 | 21.48 | 420,084 |
| 2017-02-27 | Arora Maneesh (COO) | Sale | 8,452 | 21.48 | 181,548 |
| 2017-02-27 | Coward D Scott (SVP and General Counsel) | Sale | 7,046 | 21.48 | 151,348 |
| 2017-02-27 | Lidgard Graham Peter (Chief Science Officer) | Sale | 6,001 | 21.48 | 128,901 |
| 2017-02-26 | Conroy Kevin T (President and CEO) | Option Ex | 20,025 | .00 | 0 |
| 2017-02-26 | Arora Maneesh (COO) | Option Ex | 12,150 | .00 | 0 |
| 2017-02-26 | Coward D Scott (SVP and General Counsel) | Option Ex | 21,400 | .00 | 0 |
| 2017-02-26 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 8,900 | .00 | 0 |
| 2017-02-24 | Conroy Kevin T (President and CEO) | Sale | 7,577 | 21.57 | 163,435 |
| 2017-02-24 | Conroy Kevin T (President and CEO) | Option Ex | 19,500 | .00 | 0 |
| 2017-02-24 | Arora Maneesh (COO) | Sale | 2,662 | 21.57 | 57,419 |
| 2017-02-24 | Arora Maneesh (COO) | Option Ex | 11,000 | .00 | 0 |
| 2017-02-24 | Lidgard Graham Peter (Chief Science Officer) | Sale | 2,667 | 21.57 | 57,527 |
| 2017-02-24 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 8,250 | .00 | 0 |
| 2017-02-22 | Conroy Kevin T (President and CEO) | Option Ex | 19,375 | .00 | 0 |
| 2017-02-22 | Arora Maneesh (COO) | Option Ex | 7,225 | .00 | 0 |
| 2017-02-22 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 7,225 | .00 | 0 |
| 2017-01-03 | Coward D Scott (SVP and General Counsel) | Sale | 1,535 | 13.61 | 20,891 |
| 2016-12-31 | Coward D Scott (SVP and General Counsel) | Option Ex | 4,687 | .00 | 0 |
| 2016-12-14 | Thompson David (Director) | Buy | 10,000 | 13.84 | 138,400 |
| 2016-12-05 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 127,776 | 2.88 | 367,994 |
| 2016-11-15 | Conroy Kevin T (President and CEO) | Sale | 275,000 | 17.36 | 4,774,000 |
| 2016-11-15 | Conroy Kevin T (President and CEO) | Option Ex | 33,075 | 9.07 | 299,990 |
| 2016-11-15 | Arora Maneesh (COO) | Sale | 256,466 | 17.36 | 4,452,249 |
| 2016-11-15 | Lidgard Graham Peter (Chief Science Officer) | Sale | 143,056 | 17.36 | 2,483,452 |
| 2016-11-14 | Conroy Kevin T (President and CEO) | Sale | 275,000 | 17.52 | 4,818,000 |
| 2016-11-14 | Arora Maneesh (COO) | Sale | 256,466 | 17.52 | 4,493,284 |
| 2016-11-14 | Lidgard Graham Peter (Chief Science Officer) | Sale | 143,056 | 17.52 | 2,506,341 |
| 2016-11-11 | Conroy Kevin T (President and CEO) | Sale | 50,000 | 17.68 | 884,000 |
| 2016-11-11 | Conroy Kevin T (President and CEO) | Option Ex | 600,000 | .83 | 498,000 |
| 2016-11-11 | Arora Maneesh (COO) | Sale | 50,000 | 17.68 | 884,000 |
| 2016-11-11 | Arora Maneesh (COO) | Option Ex | 562,932 | .83 | 467,233 |
| 2016-11-11 | Lidgard Graham Peter (Chief Science Officer) | Sale | 25,000 | 17.68 | 442,000 |
| 2016-11-11 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 311,112 | 2.88 | 896,002 |
| 2016-10-03 | Coward D Scott (SVP and General Counsel) | Sale | 1,701 | 17.98 | 30,583 |
| 2016-09-30 | Coward D Scott (SVP and General Counsel) | Option Ex | 4,688 | .00 | 0 |
| 2016-09-01 | Sterling Lionel (Director) | Buy | 5,000 | 18.10 | 90,500 |
| 2016-08-03 | Zanotti Katherine S (Director) | Buy | 3,380 | 17.93 | 60,613 |
| 2016-07-26 | Arora Maneesh (COO) | Sale | 7,359 | 14.82 | 109,060 |
| 2016-07-26 | Lidgard Graham Peter (Chief Science Officer) | Sale | 7,383 | 14.82 | 109,416 |
| 2016-07-25 | Conroy Kevin T (President and CEO) | Option Ex | 25,000 | .00 | 0 |
| 2016-07-25 | Arora Maneesh (COO) | Option Ex | 25,000 | .00 | 0 |
| 2016-07-25 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 25,000 | .00 | 0 |
| 2016-07-01 | Coward D Scott (SVP and General Counsel) | Sale | 1,644 | 12.28 | 20,188 |
| 2016-06-30 | Coward D Scott (SVP and General Counsel) | Option Ex | 4,687 | .00 | 0 |
| 2016-06-24 | Arora Maneesh (COO) | Option Ex | 154,568 | .83 | 128,291 |
| 2016-06-22 | Arora Maneesh (COO) | Option Ex | 90,000 | .83 | 74,700 |
| 2016-04-01 | Coward D Scott (SVP and General Counsel) | Sale | 1,685 | 6.62 | 11,154 |
| 2016-03-31 | Coward D Scott (SVP and General Counsel) | Option Ex | 4,688 | .00 | 0 |
| 2016-03-10 | Arora Maneesh (COO) | Sale | 4,042 | 6.05 | 24,454 |
| 2016-03-10 | Coward D Scott (SVP and General Counsel) | Sale | 2,175 | 6.05 | 13,158 |
| 2016-03-10 | Lidgard Graham Peter (Chief Science Officer) | Sale | 3,041 | 6.05 | 18,398 |
| 2016-03-09 | Conroy Kevin T (President and CEO) | Option Ex | 24,400 | .00 | 0 |
| 2016-03-09 | Arora Maneesh (COO) | Option Ex | 11,275 | .00 | 0 |
| 2016-03-09 | Coward D Scott (SVP and General Counsel) | Option Ex | 6,025 | .00 | 0 |
| 2016-03-09 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 8,425 | .00 | 0 |
| 2016-03-08 | Doyle James Edward (Director) | Buy | 5,000 | 6.43 | 32,150 |
| 2016-03-03 | Napier Katherine S (Director) | Buy | 3,775 | 5.38 | 20,298 |
| 2016-03-01 | Conroy Kevin T (President and CEO) | Buy | 50,000 | 5.00 | 250,000 |
| 2016-01-21 | Arora Maneesh (COO) | Option Ex | 65,000 | .83 | 53,950 |
| 2016-01-11 | Conroy Kevin T (President and CEO) | Option Ex | 265,924 | .83 | 220,716 |
| 2016-01-11 | Thompson David (Director) | Buy | 15,000 | 6.99 | 104,850 |
| 2016-01-05 | Coward D Scott (SVP and General Counsel) | Sale | 7,074 | 9.05 | 64,019 |
| 2016-01-04 | Conroy Kevin T (President and CEO) | Sale | 10,750 | 8.72 | 93,740 |
| 2016-01-04 | Arora Maneesh (COO) | Sale | 3,449 | 8.72 | 30,075 |
| 2016-01-04 | Coward D Scott (SVP and General Counsel) | Option Ex | 18,750 | .00 | 0 |
| 2016-01-04 | Lidgard Graham Peter (Chief Science Officer) | Sale | 3,463 | 8.72 | 30,197 |
| 2015-12-31 | Conroy Kevin T (President and CEO) | Option Ex | 20,466 | .00 | 0 |
| 2015-12-31 | Arora Maneesh (COO) | Option Ex | 6,566 | .00 | 0 |
| 2015-12-31 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 6,566 | .00 | 0 |
| 2015-12-30 | Arora Maneesh (COO) | Option Ex | 50,000 | .83 | 41,500 |
| 2015-12-23 | Conroy Kevin T (President and CEO) | Option Ex | 81,000 | .83 | 67,230 |
| 2015-08-26 | Megan William J. (SVP, Finance) | Option Ex | 15,000 | .00 | 0 |
| 2015-07-27 | Conroy Kevin T (President and CEO) | Sale | 11,386 | 24.04 | 273,719 |
| 2015-07-27 | Arora Maneesh (COO) | Sale | 9,332 | 24.04 | 224,341 |
| 2015-07-27 | Lidgard Graham Peter (Chief Science Officer) | Sale | 12,579 | 24.04 | 302,399 |
| 2015-07-25 | Conroy Kevin T (President and CEO) | Option Ex | 25,000 | .00 | 0 |
| 2015-07-25 | Arora Maneesh (COO) | Option Ex | 25,000 | .00 | 0 |
| 2015-07-25 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 25,000 | .00 | 0 |
| 2015-02-26 | Conroy Kevin T (President and CEO) | Sale | 8,425 | 23.44 | 197,482 |
| 2015-02-26 | Arora Maneesh (COO) | Sale | 3,895 | 23.44 | 91,298 |
| 2015-02-26 | Lidgard Graham Peter (Director) | Sale | 3,938 | 23.44 | 92,306 |
| 2015-02-24 | Megan William J. (SVP, Finance & PFO) | Option Ex | 2,250 | .00 | 0 |
| 2015-02-24 | Conroy Kevin T (President and CEO) | Sale | 9,798 | 22.90 | 224,374 |
| 2015-02-24 | Conroy Kevin T (President and CEO) | Option Ex | 19,500 | .00 | 0 |
| 2015-02-24 | Arora Maneesh (COO) | Sale | 2,995 | 22.90 | 68,585 |
| 2015-02-24 | Arora Maneesh (COO) | Option Ex | 11,000 | .00 | 0 |
| 2015-02-24 | Lidgard Graham Peter (Director) | Sale | 4,037 | 22.90 | 92,447 |
| 2015-02-24 | Lidgard Graham Peter (Director) | Option Ex | 8,250 | .00 | 0 |
| 2015-02-23 | Conroy Kevin T (President and CEO) | Option Ex | 19,375 | .00 | 0 |
| 2015-02-23 | Arora Maneesh (COO) | Option Ex | 7,225 | .00 | 0 |
| 2015-02-23 | Lidgard Graham Peter (Director) | Option Ex | 7,225 | .00 | 0 |
| 2015-01-02 | Conroy Kevin T (President and CEO) | Sale | 9,484 | 26.72 | 253,412 |
| 2015-01-02 | Arora Maneesh (COO) | Sale | 2,495 | 26.72 | 66,666 |
| 2015-01-02 | Lidgard Graham Peter (Chief Science Officer) | Sale | 3,363 | 26.72 | 89,859 |
| 2014-12-31 | Conroy Kevin T (President and CEO) | Option Ex | 20,467 | .00 | 0 |
| 2014-12-31 | Arora Maneesh (COO) | Option Ex | 6,567 | .00 | 0 |
| 2014-12-31 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 6,567 | .00 | 0 |
| 2001-06-02 | Carey Thomas D. (Director) | Sale | 17,000 | 108.11 | 1,837,870 |
Insider trading activities including stock purchases, stock sales, and option exercises of EXAS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Exact Sciences Corp (symbol EXAS, CIK number 1124140) see the Securities and Exchange Commission (SEC) website.